A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Fragment- [5-31]-Liraglutide - 请求报价

Fragment- [5-31]-Liraglutide

添加到收藏夹

SZ目录编号:	SZ-L098005
CAS 号	NA
分子式	C156H243N37O45
分子量	3356.9
投资状态	Synthesis on demand
运输条件	Cold Shipment -20°C

需要帮助吗？

产品概览描述技术数据

化学名称 :N5-((2S,5S,8S,11S,14S,17S)-17-((S)-2-((S)-2-((S)-5-amino-2-(2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((2S,3R)-2-((S)-2-((2S,3R)-2-amino-3-hydroxybutanamido)-3-phenylpropanamido)-3-hydroxybutanamido)-3-hydroxypropanamido)-3-carboxypropanamido)-3-methylbutanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-3-(4-hydroxyphenyl)propanamido)-4-methylpentanamido)-4-carboxybutanamido)acetamido)-5-oxopentanamido)propanamido)propanamido)-11-benzyl-8-((S)-sec-butyl)-14-(2-carboxyethyl)-2-(((S)-1-(((S)-1-(((S)-1-((2-(((S)-1-((carboxymethyl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)-1-(1H-indol-3-yl)-5-methyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazahenicosan-21-yl)-N2-palmitoyl-L-glutamine

运输温度 : Cold Shipment -20°C

HSN编码 :38229010

原产国 : India

微笑 :CCCCCCCCCCCCCCCC(N[C@H](C(O)=O)CCC(NCCCC[C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(NCC(O)=O)=O)CCCNC(N)=N)=O)=O)CCCNC(N)=N)=O)C(C)C)=O)CC(C)C)=O)CC1=CNC2=CC=CC=C12)=O)C)=O)[C@H](CC)C)=O)CC3=CC=CC=C3)=O)CCC(O)=O)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](C(C)C)NC([C@@H](NC([C@@H](NC([C@H]([C@H](O)C)NC([C@@H](NC([C@H]([C@H](O)C)N)=O)CC4=CC=CC=C4)=O)=O)CO)=O)CC(O)=O)=O)=O)CO)=O)CO)=O)CC5=CC=C(C=C5)O)=O)CC(C)C)=O)CCC(O)=O)=O)=O)CCC(N)=O)=O)C)=O)C)=O)=O)=O

使用说明:所提供的化合物仅供实验室、研究、分析和科学用途，不可用于人体。

Fragment- [5-31]-Liraglutide is chemically N5-((2S,5S,8S,11S,14S,17S)-17-((S)-2-((S)-2-((S)-5-amino-2-(2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((S)-2-((2S,3R)-2-((S)-2-((2S,3R)-2-amino-3-hydroxybutanamido)-3-phenylpropanamido)-3-hydroxybutanamido)-3-hydroxypropanamido)-3-carboxypropanamido)-3-methylbutanamido)-3-hydroxypropanamido)-3-hydroxypropanamido)-3-(4-hydroxyphenyl)propanamido)-4-methylpentanamido)-4-carboxybutanamido)acetamido)-5-oxopentanamido)propanamido)propanamido)-11-benzyl-8-((S)-sec-butyl)-14-(2-carboxyethyl)-2-(((S)-1-(((S)-1-(((S)-1-((2-(((S)-1-((carboxymethyl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)-1-(1H-indol-3-yl)-5-methyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazahenicosan-21-yl)-N2-palmitoyl-L-glutamine. Fragment- [5-31]-Liraglutide is supplied with detailed characterization data compliant with regulatory guideline. Fragment- [5-31]-Liraglutide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Liraglutide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.